Stock Ratings / Health Care / ALMR / options

PACB (37) CTKB (41) BRKR (59) BIO (66) ⌘ Pro Terminal →

Alamar Biosciences Inc. (ALMR) Options Positioning, Max Pain & Unusual Sweeps

$34.04 -0.76% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Alamar Biosciences Inc. (ALMR) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $2.36B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ALMR)Realized 20D OHLCV Swing Band: ±12.5%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (ALMR)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for ALMR.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ALMR)

✓Walkthrough of ALMR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ALMR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +35.94%▲ ASCENDING CHANNEL

2026-10-30O $33.35H $34.04L $29.36C $34.04VOL 740.0K

RES: $40.10SUP: $23.49SMA50: $30.65SMA200: $26.93

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ALMR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ALMR Butterfly Map → + Track ALMR →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ALMR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ALMR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ALMR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ALMR)

Health Care Rank #378 of 1016 ⚔️ PACB vs ALMR Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ALMR vs. PACB, CTKB, BRKR, BIO)

Industry: Biotechnology: Laboratory Analytical Instruments (21 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Alamar Biosciences Inc. (ALMR) ranks #378 by composite RQD confidence (48/100, grade D) and #230 by equity capitalization ($2.36B). Within this direct 5-issuer industry benchmark cohort, BIO leads on earnings valuation at 13.5x trailing P/E, while BRKR leads on capital efficiency and profitability with 1.3% ROIC and 45.9% gross margin. BIO currently holds the highest overall quantitative score in the immediate peer group at 66/100 (C+) compared with ALMR at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ALMR ACTIVE Alamar Biosciences Inc.	D	48/100	—	—	—	-0.76%	$2.36B	Benchmark Subject
PACB Pacific Biosciences of California Inc.	D-	37/100	—	28.6%	-35.0%	+2.47%	$901.4M	/pacb-vs-almr →
CTKB Cytek Biosciences Inc.	D-	41/100	—	51.8%	-12.7%	+2.61%	$818.9M	/ctkb-vs-almr →
BRKR Bruker Corporation	C-	59/100	—	45.9%	1.3%	0.00%	$9.45B	/brkr-vs-almr →
BIO Bio-Rad Laboratories Inc.	C+	66/100	13.5x	51.9%	0.5%	-0.19%	$10.28B	/bio-vs-almr →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002104204

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alamar Biosciences Inc. (ALMR) reported GAAP revenue of $0 , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, ALMR closed FY2025 with $140.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	$0	—	—	$140.0M	—

3. ALMR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ALMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Alamar Biosciences Inc. (NASDAQ: ALMR) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $34.04 (-0.76% 1D, market cap $2.36B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, ALMR ranks #378 in composite RQD confidence.

How does ALMR compare to PACB and CTKB in the Health Care sector?

Within the Health Care sector (Biotechnology: Laboratory Analytical Instruments), ALMR carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, PACB (Pacific Biosciences of California Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $901.4M) and CTKB (Cytek Biosciences Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -12.7%, cap $818.9M). Among the 5-stock peer group, BIO leads on earnings multiple (13.5x) while BRKR leads on capital efficiency (1.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ALMR?

Per ALMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002104204), Alamar Biosciences Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $140.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ALMR trading relative to its 50-day, 200-day, and 52-week technical levels?

ALMR last traded at $34.04 (-0.76% on volume of 496,166 shares), positioning the stock +11.06% above its 50-day simple moving average ($30.65) and +26.40% above its 200-day simple moving average ($26.93). Across its 52-week range of $18.85 to $39.61, ALMR sits at the 73.2% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($29.79 to $38.29).

ALMR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ALMR's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for ALMR.

Direct Sub-Reports: ALMR RQD Cockpit ALMR 12M Forecast ALMR Earnings & Move ALMR Dividends & DRIP ALMR Insiders & 13F ALMR Whale Options ALMR Profit Sankey ALMR News & Why